Vaccine Safety & Efficacy


Vaccine efficacy refers to the ability of vaccines to bring about the intended beneficial effects on vaccinated individuals in a defined population under ideal conditions of use. The potential benefits of an effective vaccine – e.g. promotion of health and well-being, and protection from illness and its physical, psychological and socioeconomic consequences must be weighed against the potential risk of an adverse event following immunization (AEFI) with that vaccine. Vaccine-associated risk is the probability of an adverse or unwanted outcome occurring, and the severity of the resulting harm to the health of vaccinated individuals in a defined population following immunization with a vaccine under ideal conditions of use.


  • Usage and awareness in public
  • Anaphylaxis
  • Vaccine safety and quality
  • Anaphylactic hypersensitivity
  • Safe immunization schedules
  • Quality control and assurance of vaccines
  • Safety and efficacy of attenuated vaccine
  • Biomarkers for vaccine safety and efficacy

Related Conference of Vaccine Safety & Efficacy

May 30-31, 2024

World congress on Immunology and Virology Diseases

Vienna, Austria
August 01-02, 2024

44th Global Summit and Expo on Vaccines & Immunology

Montreal, Canada
September 09-10, 2024

4th International Conference on Vaccine Research

Madrid, Spain
November 28-29, 2024

6th World Congress on Vaccine and Immunology

Paris, France

Vaccine Safety & Efficacy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in